AMG
38
2
GOOGL
50
2
ETN
69
-4
CVX
38
3
FITB
58
5
HSY
40
2
GD
62
2
PLD
58
-3
ADM
33
5
FFIV
67
3
FMC
36
6
AVGO
52
-19
DNB
54
4
SIG
57
7
URI
53
3
ZBH
59
3
ROK
47
3
KMX
47
3
UNM
72
2
BBY
58
5
AMG
38
2
GOOGL
50
2
ETN
69
-4
CVX
38
3
FITB
58
5
HSY
40
2
GD
62
2
PLD
58
-3
ADM
33
5
FFIV
67
3
FMC
36
6
AVGO
52
-19
DNB
54
4
SIG
57
7
URI
53
3
ZBH
59
3
ROK
47
3
KMX
47
3
UNM
72
2
BBY
58
5
Financhill
Back

C4 Therapeutics Quote, Financials, Valuation and Earnings

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
24

CCCC
C4 Therapeutics

Last Price:
6.32
Seasonality Move:
-34.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Hope Is Not a Strategy!

Learn More

C4 Therapeutics Price Quote

$6.32
-0.12 (-1.86%)
(Updated: September 16, 2024 at 3:20 PM ET)

C4 Therapeutics Key Stats

Sell
24
C4 Therapeutics (CCCC) is a Sell
Day range:
$5.70 - $7.22
52-week range:
$1.06 - $11.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.03
P/B ratio:
1.81%
Volume:
3.3M
Avg. volume:
1.1M
1-year change:
178.79%
Market cap:
$446.5M
Revenue:
$20.8M
EPS:
$-1.9

How Much Does C4 Therapeutics Make?

Is C4 Therapeutics Growing As A Company?

  • What Is C4 Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.51%
  • What Is C4 Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

C4 Therapeutics Stock Price Performance

  • Did C4 Therapeutics Stock Go Up Last Month?
    C4 Therapeutics share price went up by 12.98% last month
  • Did CCCC's Share Price Rise Over The Last Year?
    CCCC share price rose by 178.79% over the past 1 year

What Is C4 Therapeutics 52-Week High & Low?

C4 Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy C4 Therapeutics?

  • How Much Debt Does C4 Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does C4 Therapeutics Have?
    Cash and short term investments quarterly total is $264.1M
  • What Is C4 Therapeutics’s Book Value Per Share?
    Book value per share is 3.59

Is C4 Therapeutics Cash Flow Positive?

  • What Is CCCC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$77.8M
  • What Is C4 Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $81.6M
  • What Is C4 Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $24.6M

C4 Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CCCC return on invested capital is -44.52%
  • What Is C4 Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -28.94%
  • What Is CCCC Return On Equity?
    ROE is a measure of profitability and is -44.9%

C4 Therapeutics Earnings Date & Stock Price

C4 Therapeutics Competitors

  • Who Are C4 Therapeutics's Competitors?
    Below is a list of companies who compete with C4 Therapeutics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Biogen Inc (BIIB)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • Praxis Precision Medicines Inc (PRAX)

C4 Therapeutics Dividend Yield

C4 Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -44.44%
Revenue: 350.68% 151%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 14.88
Upside from Last Price: 130.98%

Major Shareholders

  • How many CCCC shares are owned by institutional investors?
    77.4M CCCC shares are owned by institutional investors
  • How many CCCC shares are owned by insiders?
    1.4M CCCC shares are owned by insiders